Published on : Aug 23, 2016
ALBANY, New York, August 23, 2016: ResearchMoz.us has added a new report, titled “Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021)” to its offering. This report presents a detailed evaluation of the market for transcatheter mitral valve replacement (TMVR). It analyzes the market on the basis of volume, value, segment, and penetration rate.
The factors currently impacting the growth of the market have been presented in this study. Furthermore, industry-relevant news, key trends, and the problems encountered by the key players operating in the market have been encapsulated in this report. The state of this market has been studied in both Europe and the U.S.
The introduction section of this study presents an overview of heart valves and mitral regurgitation. The types of mitral regurgitation and a comparative analysis on mitral valve and aortic valve have been presented in this section of the report. Mitral regurgitation is amongst the most common heart valve disorders.
The two types of mitral regurgitations are functional and degenerative mitral regurgitation. These two types can further be categorized into a number of sub-types. At present, there are a number of approaches utilized in replacement surgery, based on the type of disease.
Click here to get more info with TOC in a PDF Format: https://www.researchmoz.us/enquiry.php?type=S&repid=770185
In the following part of the report, the global transcatheter mitral valve replacement (TMVR) market is analyzed in terms of patient severity and number of patients suffering from this disorder in both the U.S. and Europe. As per the report, the TMVR market is presently in a nascent stage, with a number of companies manufacturing various TMVR devices. The report also states that commercial TMVR devices are predicted to be introduced in the next two to three years.
Moving further, the report sheds light on the factors driving and impeding the growth of the global TMVR market. The increasing number of individuals suffering from rheumatic fever and congenital heart defects and the globally rising geriatric population are amongst the prime factors providing impetus to the market.
In addition, a plethora of new approaches being adopted in the TMVR market will increase the success rate of the treatment, thus augmenting the growth of the overall market. On the other hand, the increasing design complexity of TMVR devices may negatively impact the growth of the market. Moreover, the positive outcomes of repair surgery used as an alternative to TMVR devices threatens the market.
In the last section of the study, the competitive landscape section has been presented, discussing the company profiles of the prime players dominant in the TMVR market. Edward Lifesciences Incorporation, Medtronic, and Abbott Laboratories are among the key players in the market.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on email@example.com